[go: up one dir, main page]

TR200900879A2 - Pharmaceutical compositions in which the active ingredients are combined in a single dosage form - Google Patents

Pharmaceutical compositions in which the active ingredients are combined in a single dosage form

Info

Publication number
TR200900879A2
TR200900879A2 TR2009/00879A TR200900879A TR200900879A2 TR 200900879 A2 TR200900879 A2 TR 200900879A2 TR 2009/00879 A TR2009/00879 A TR 2009/00879A TR 200900879 A TR200900879 A TR 200900879A TR 200900879 A2 TR200900879 A2 TR 200900879A2
Authority
TR
Turkey
Prior art keywords
combined
pharmaceutical compositions
dosage form
active ingredients
single dosage
Prior art date
Application number
TR2009/00879A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2009/00879A priority Critical patent/TR200900879A2/en
Priority to PCT/TR2010/000025 priority patent/WO2010101537A1/en
Publication of TR200900879A2 publication Critical patent/TR200900879A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş, aktif maddelerin hastanın tedaviye uyumunu ve dolayısıyla tedavinin başarısını artırmak üzere tek bir dozaj formunda kombine edildiği farmasötik bileşimlere ilişkindir.The present invention relates to pharmaceutical compositions in which the active ingredients are combined in a single dosage form to increase patient compliance and hence the success of the treatment.

TR2009/00879A 2009-02-05 2009-02-05 Pharmaceutical compositions in which the active ingredients are combined in a single dosage form TR200900879A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2009/00879A TR200900879A2 (en) 2009-02-05 2009-02-05 Pharmaceutical compositions in which the active ingredients are combined in a single dosage form
PCT/TR2010/000025 WO2010101537A1 (en) 2009-02-05 2010-02-02 Pharmaceutical composition of alendronate and a calcium salt combined in a single dosage form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2009/00879A TR200900879A2 (en) 2009-02-05 2009-02-05 Pharmaceutical compositions in which the active ingredients are combined in a single dosage form

Publications (1)

Publication Number Publication Date
TR200900879A2 true TR200900879A2 (en) 2010-08-23

Family

ID=42245666

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2009/00879A TR200900879A2 (en) 2009-02-05 2009-02-05 Pharmaceutical compositions in which the active ingredients are combined in a single dosage form

Country Status (2)

Country Link
TR (1) TR200900879A2 (en)
WO (1) WO2010101537A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2648702T (en) 2010-12-06 2019-03-29 Effrx Pharmaceuticals Sa Stable effervescent bisphosphonate formulations with rapid solubilization characteristics
RS59534B1 (en) 2014-02-13 2019-12-31 Incyte Corp Cyclopropylamines as lsd1 inhibitors
PH12020552066A1 (en) 2014-02-13 2022-05-11 Incyte Corp Cyclopropylamines as lsd1 inhibitors
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
EP3626720A1 (en) 2015-04-03 2020-03-25 Incyte Corporation Heterocyclic compounds as lsd1 inhibitors
MX389824B (en) 2015-08-12 2025-03-20 Incyte Holdings Corp SALTS OF A LYSINE-SPECIFIC DIMETHYLASE 1 INHIBITOR (LSD1).
US10968200B2 (en) 2018-08-31 2021-04-06 Incyte Corporation Salts of an LSD1 inhibitor and processes for preparing the same
CN116285419B (en) * 2023-03-20 2025-08-01 贺州学院 Method for preparing heavy calcium carbonate with low oil absorption value by using composite surface modifier

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040188316A1 (en) * 2003-03-26 2004-09-30 The Procter & Gamble Company Kit for pharmaceutical use
CA2622322A1 (en) * 2005-09-16 2007-03-22 Selamine Ltd Bisphosphonate formulation

Also Published As

Publication number Publication date
WO2010101537A1 (en) 2010-09-10

Similar Documents

Publication Publication Date Title
TR200900878A2 (en) Pharmaceutical formulations combined in a single dosage form
CY1118661T1 (en) PHARMACEUTICAL COMPOSITION, PHARMACEUTICAL DOSAGE FORM, PROCEDURE FOR THEIR PREPARATION, METHODS FOR TREATMENT AND USE OF THESE
TR200900879A2 (en) Pharmaceutical compositions in which the active ingredients are combined in a single dosage form
CY1118813T1 (en) PHARMACEUTICAL COMPOSITIONS OF TRAMADOL AND COXYL-CYLINDERS
IN2012DN06720A (en)
MX350046B (en) Treatments for gastrointestinal disorders.
EA201290171A1 (en) INTRODUCED ORAL CORRECTIC STERILE COMPOSITIONS
MX344238B (en) Tetrazole compounds and methods of making and using same.
HN2011003011A (en) SUBLINGUAL COMPOSITIONS OF DEXMEDETOMIDINE AND METHODS OF USE OF THEM
EA201492290A1 (en) COMPOSITIONS AND METHODS FOR VAGINAL DELIVERY OF ANTIPROGHESTINES
MX2011008634A (en) Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy.
EA201200937A1 (en) SOLID MEDICINE FORM TICAGRELOR
MY161595A (en) Oral care compositions
PH12012501620A1 (en) Oral care compositions
GB2523707A (en) Novel pharmaceutical formulations and their use in the treatment of periodontal disease
TN2015000135A1 (en) Modified release formulations for oprozomib
TR201009394A2 (en) Improved montelukast formulations.
EA201390950A1 (en) HOMOGENEOUS PHARMACEUTICAL ORAL DOSAGE FORMS CONTAINING LERKANIDIPIN AND ENALAPRIL OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS TOGETHER WITH ORGANIC ACID
TR200806300A2 (en) Solubility enhancing pharmaceutical formulation
TR200900880A2 (en) Pharmaceutical compositions combined in a single dosage form.
TR200900881A2 (en) Stable pharmaceutical compositions masked by taste and odor
TR200909785A1 (en) Pharmaceutical compositions containing cefdinir as the active agent.
TR200906506A2 (en) Solid dosage forms containing telmisartan.
TR201005327A2 (en) Synergistic pharmaceutical formulations.
EA201291420A1 (en) ORAL MEDICAL FORMS CONTAINING LERCANIDIPIN AND ENALAPRIL AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS